# Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

> **NCT04203017** · PHASE1 · TERMINATED · sponsor: **St. Petersburg State Pavlov Medical University** · enrollment: 20 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** allogeneic fecal microbiota

## Key facts

- **NCT ID:** NCT04203017
- **Lead sponsor:** St. Petersburg State Pavlov Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-01
- **Primary completion:** 2023-11-29
- **Final completion:** 2023-11-29
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** the bio-samples are corrupted for technical reasons
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04203017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04203017, "Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04203017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*